Literature DB >> 18450748

Homo-oligomerization is essential for Toll/interleukin-1 receptor domain-containing adaptor molecule-1-mediated NF-kappaB and interferon regulatory factor-3 activation.

Kenji Funami1, Miwa Sasai, Hiroyuki Oshiumi, Tsukasa Seya, Misako Matsumoto.   

Abstract

Toll-IL-1 receptor (TIR) domain-containing adaptor molecule-1 (TICAM-1, also named TIR domain-containing adaptor-inducing interferon (IFN)-beta or TRIF)) is a signaling adaptor of Toll-like receptor (TLR) 3/4 that activates the transcription factors, interferon regulatory factor-3 (IRF-3) and NF-kappaB leading to inducing IFN-beta production. The mechanisms by which TICAM-1 is activated by TLR3/4 to serve as a signaling platform are unknown. In this study, we show that homo-oligomerization of TICAM-1 is critical for TICAM-1-mediated activation of NF-kappaB and IRF-3. Both TIR and C-terminal domain of TICAM-1 mediated TICAM-1 oligomerization. Pro(434) located in the TIR domain and the C-terminal region, with the exception of the RIP homotypic-interacting motif, were determinants of TICAM-1 oligomerization. Mutation of TIR domain (P434H) or deletion of C-terminal domain greatly reduced TICAM-1-mediated NF-kappaB and IFN-beta promoter activation. TICAM-1 oligomerization at either the TIR domain or the C-terminal region resulted in recruitment of tumor necrosis factor receptor-associated factor 3, a downstream signaling molecule essential for TICAM-1-mediated IRF-3 activation, but not recruitment of the IRF-3 kinase complex, NF-kappaB-activating kinase-associated protein 1 and TANK-binding kinase 1. In addition, RIP homotypic-interacting motif mutant, which possesses two oligomerization motifs but not the RIP1 binding motif, also failed to recruit NF-kappaB-activating kinase-associated protein 1 and TANK-binding kinase 1. Thus, full activation and formation of TICAM-1 signalosomes requires oligomerization induced at two different sites and RIP1 binding.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18450748      PMCID: PMC2440629          DOI: 10.1074/jbc.M801013200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling.

Authors:  Jonathan C Kagan; Ruslan Medzhitov
Journal:  Cell       Date:  2006-06-02       Impact factor: 41.582

2.  Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif.

Authors:  Supriya K Saha; Eric M Pietras; Jeannie Q He; Jason R Kang; Su-Yang Liu; Gagik Oganesyan; Arash Shahangian; Brian Zarnegar; Travis L Shiba; Yao Wang; Genhong Cheng
Journal:  EMBO J       Date:  2006-07-06       Impact factor: 11.598

3.  Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells.

Authors:  Takashi Akazawa; Takashi Ebihara; Manabu Okuno; Yu Okuda; Masashi Shingai; Kunio Tsujimura; Toshitada Takahashi; Masahito Ikawa; Masaru Okabe; Norimitsu Inoue; Miki Okamoto-Tanaka; Hiroyoshi Ishizaki; Jun Miyoshi; Misako Matsumoto; Tsukasa Seya
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-26       Impact factor: 11.205

4.  NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction.

Authors:  Miwa Sasai; Masashi Shingai; Kenji Funami; Mitsutoshi Yoneyama; Takashi Fujita; Misako Matsumoto; Tsukasa Seya
Journal:  J Immunol       Date:  2006-12-15       Impact factor: 5.422

5.  The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction.

Authors:  Daniel C Rowe; Anne F McGettrick; Eicke Latz; Brian G Monks; Nicholas J Gay; Masahiro Yamamoto; Shizuo Akira; Luke A O'Neill; Katherine A Fitzgerald; Douglas T Golenbock
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-07       Impact factor: 11.205

6.  Structural basis for signal transduction by the Toll/interleukin-1 receptor domains.

Authors:  Y Xu; X Tao; B Shen; T Horng; R Medzhitov; J L Manley; L Tong
Journal:  Nature       Date:  2000-11-02       Impact factor: 49.962

7.  DUBA: a deubiquitinase that regulates type I interferon production.

Authors:  Nobuhiko Kayagaki; Qui Phung; Salina Chan; Ruchir Chaudhari; Casey Quan; Karen M O'Rourke; Michael Eby; Eric Pietras; Genhong Cheng; J Fernando Bazan; Zemin Zhang; David Arnott; Vishva M Dixit
Journal:  Science       Date:  2007-11-08       Impact factor: 47.728

8.  Spatiotemporal mobilization of Toll/IL-1 receptor domain-containing adaptor molecule-1 in response to dsRNA.

Authors:  Kenji Funami; Miwa Sasai; Yusuke Ohba; Hiroyuki Oshiumi; Tsukasa Seya; Misako Matsumoto
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

9.  MyD88-dependent and -independent signaling by IL-1 in neurons probed by bifunctional Toll/IL-1 receptor domain/BB-loop mimetics.

Authors:  Christopher N Davis; Enrique Mann; M Margarita Behrens; Svetlana Gaidarova; Mitra Rebek; Julius Rebek; Tamas Bartfai
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

10.  Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound.

Authors:  Maria Loiarro; Federica Capolunghi; Nicola Fantò; Grazia Gallo; Silvia Campo; Brunilde Arseni; Rita Carsetti; Paolo Carminati; Rita De Santis; Vito Ruggiero; Claudio Sette
Journal:  J Leukoc Biol       Date:  2007-06-04       Impact factor: 4.962

View more
  29 in total

1.  TRIF modulates TLR5-dependent responses by inducing proteolytic degradation of TLR5.

Authors:  Yoon Jeong Choi; Eunok Im; Charalabos Pothoulakis; Sang Hoon Rhee
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

2.  Characterization of bbtTICAM from amphioxus suggests the emergence of a MyD88-independent pathway in basal chordates.

Authors:  Manyi Yang; Shaochun Yuan; Shengfeng Huang; Jun Li; Liqun Xu; Huiqing Huang; Xin Tao; Jian Peng; Anlong Xu
Journal:  Cell Res       Date:  2011-09-20       Impact factor: 25.617

3.  ZCCHC3 modulates TLR3-mediated signaling by promoting recruitment of TRIF to TLR3.

Authors:  Ru Zang; Huan Lian; Xuan Zhong; Qing Yang; Hong-Bing Shu
Journal:  J Mol Cell Biol       Date:  2020-05-18       Impact factor: 6.216

4.  The N-terminal domain of TIR domain-containing adaptor molecule-1, TICAM-1.

Authors:  Hiroyuki Kumeta; Hiromi Sakakibara; Yoshiaki Enokizono; Kenji Ogura; Masataka Horiuchi; Misako Matsumoto; Tsukasa Seya; Fuyuhiko Inagaki
Journal:  J Biomol NMR       Date:  2014-02-06       Impact factor: 2.835

Review 5.  Inborn errors of anti-viral interferon immunity in humans.

Authors:  Vanessa Sancho-Shimizu; Rebeca Perez de Diego; Emmanuelle Jouanguy; Shen-Ying Zhang; Jean-Laurent Casanova
Journal:  Curr Opin Virol       Date:  2011-12       Impact factor: 7.090

6.  Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency.

Authors:  Vanessa Sancho-Shimizu; Rebeca Pérez de Diego; Lazaro Lorenzo; Rabih Halwani; Abdullah Alangari; Elisabeth Israelsson; Sylvie Fabrega; Annabelle Cardon; Jerome Maluenda; Megumi Tatematsu; Farhad Mahvelati; Melina Herman; Michael Ciancanelli; Yiqi Guo; Zobaida AlSum; Nouf Alkhamis; Abdulkarim S Al-Makadma; Ata Ghadiri; Soraya Boucherit; Sabine Plancoulaine; Capucine Picard; Flore Rozenberg; Marc Tardieu; Pierre Lebon; Emmanuelle Jouanguy; Nima Rezaei; Tsukasa Seya; Misako Matsumoto; Damien Chaussabel; Anne Puel; Shen-Ying Zhang; Laurent Abel; Saleh Al-Muhsen; Jean-Laurent Casanova
Journal:  J Clin Invest       Date:  2011-11-21       Impact factor: 14.808

7.  Analysis of a TIR-less splice variant of TRIF reveals an unexpected mechanism of TLR3-mediated signaling.

Authors:  Ke-Jun Han; Yan Yang; Liang-Guo Xu; Hong-Bing Shu
Journal:  J Biol Chem       Date:  2010-03-03       Impact factor: 5.157

8.  Structures and interface mapping of the TIR domain-containing adaptor molecules involved in interferon signaling.

Authors:  Yoshiaki Enokizono; Hiroyuki Kumeta; Kenji Funami; Masataka Horiuchi; Joy Sarmiento; Kazuo Yamashita; Daron M Standley; Misako Matsumoto; Tsukasa Seya; Fuyuhiko Inagaki
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-19       Impact factor: 11.205

9.  A new domain in the Toll/IL-1R domain-containing adaptor inducing interferon-β factor protein amino terminus is important for tumor necrosis factor-α receptor-associated factor 3 association, protein stabilization and interferon signaling.

Authors:  Vinh-Phuc Nguyen; Jing Chen; Michael N Petrus; Carolyn K Goldman; Michael J Kruhlak; Richard N Bamford; Thomas A Waldmann
Journal:  J Innate Immun       Date:  2014-02-26       Impact factor: 7.349

10.  ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization.

Authors:  Wenxiang Sun; Yang Li; Lu Chen; Huihui Chen; Fuping You; Xiang Zhou; Yi Zhou; Zhonghe Zhai; Danying Chen; Zhengfan Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.